A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity
Clinical trial NCT01180465 · COMPLETED
Trial details
- NCT number
- NCT01180465
- Sponsor
- Neothetics, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2010-09-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.